Pharmacy Residency
Left to right: Evan Cross, PharmD, PGY2 Oncology Resident; Z Ni, PharmD, PGY2 Pediatrics Resident; Vivian Le, PharmD, PGY1 Pharmacy Resident; Anastasia Tentoglou, PharmD, PGY1 Pharmacy Resident
Seattle Children's Pharmacy Residency Programs
Welcome to our informational page on pharmacy residency training! Our institution currently offers three residency programs:
- PGY1 Pharmacy Residency (ASHP match code 95351)
- PGY2 Pediatrics Residency (ASHP match code 95914)
- PGY2 Oncology Residency (ASHP match code 95017)
Our pages offer guidance on requirements for these programs in addition to background on offered rotations, longitudinal experiences and research.
We find strength in our patients, their families, caregivers, staff and community. We believe all children deserve exceptional care, the best outcomes, respect and a safe environment. Our residency program includes opportunities to improve healthcare experiences and outcomes for all patients, families and caregivers.
Why do a residency at Seattle Children’s Hospital?
- Strong professional and collaborative relationships between physicians, APPs, nurses and pharmacists
- Culture of safety to ensure the most effective and safest care for our patients
- Experienced and well-rounded preceptors with involvement in policy, pathway and guideline of care development
- Supportive learning environment for pharmacy residents, interns and students
- Because you are the future of pharmacy! Come train with a fun and knowledgeable group of practitioners.
- Practice at a large referral center to obtain a well-rounded learning experience
PGY1 and PGY2 Preceptors
Sonya Barich, PharmD
Hematology/Oncology
PGY2 Oncology Residency Program Director
Pharmacy School: University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences
Residency Training:
- PGY1: Seattle Children’s Hospital
- PGY2 Oncology: Seattle Children’s Hospital
Emily Benefield, PharmD, MHA, BCPS, BCPPS, FPPA
Pharmacy Administration
Pharmacy School: Washington State University
Residency Training:
- PGY1: University of Oklahoma
- PGY2 Pediatrics: University of Oklahoma
Adam Brothers, PharmD
Antimicrobial Stewardship
Pharmacy School: University of Washington
Residency Training: PGY1: University of Wisconsin Hospital and Clinics
Anny Chan, PharmD
Bone Marrow Transplant
Hannah Christensen, PharmD, BCPP
Pediatric and Adolescent Psychiatry
Pharmacy School: University of Utah College of Pharmacy
Residency Training:
- PGY1: Prisma Health Upstate
- PGY2 Psychiatry: University of Michigan Health
Andrea Ewing, PharmD
Pharmacy Operations Educator
Pharmacy School: Washington State University
Residency Training: PGY1: MultiCare Health System, Tacoma General and Mary Bridge Children’s Hospital
Shiho Fukasawa, PharmD
Liver and Abdominal Transplant
Pharmacy School: University of Washington
Alina Herman, PharmD, BCPS
Bone Marrow Transplant
Pharmacy School: Washington State University
Karyl Kanada, PharmD
Emergency Medicine
Pharmacy School: University of Minnesota College of Pharmacy
Residency Training: PGY1: Seattle Children’s Hospital
Sai Karwande, PharmD, BCCCP
Pediatric Intensive Care
William Korab, PharmD, BCPS
Pediatric General Medicine/Surgery
Pharmacy School: Drake University College of Pharmacy and Health Sciences
Residency Training: PGY1: Advocate Christ Medical Center and Advocate Children’s Hospital (formerly Hope Children’s Hospital)
Francine Lai, PharmD
Outpatient Anticoagulation Service
Pharmacy School: University of Washington
Dominique Mark, PharmD, BCPS, BCPPS
Residency Program Director, PGY1 Pharmacy and PGY2 Pediatrics
Pediatric General Medicine/Surgery
Pharmacy School: University of Arizona College of Pharmacy
Residency Training:
- PGY1: University Medical Center of Southern Nevada (UMCSN)
- PGY2 Pediatrics: University of California, San Francisco (UCSF)
Kris Martinson, PharmD
Hematology/Oncology and Bone Marrow Transplant Supervisor
Pharmacy School: University of Washington
Residency Training:
- PGY1: University of Washington
- PGY2 Oncology: Seattle Children’s Hospital
Tom Nemeth, PharmD
Cardiac and Abdominal Solid Organ Transplant
David Newland, PharmD, BCPS, BCTXP
Heart Center Lead Pharmacist
Cardiac Solid Organ Transplant
Pharmacy School: Pacific University School of Pharmacy
Residency Training
- PGY1: VA Puget Sound Health Care System
- PGY2 Solid Organ Transplant: University Health/UT Health
Jennifer Nguyen, PharmD
Pediatric General Medicine/Surgery
Pharmacy School: Creighton University School of Pharmacy and Health Professions
Residency Training: PGY1: Seattle Children’s Hospital
Jenna Nickless, PharmD, BCCCP
Pediatric and Cardiac Intensive Care
Pharmacy School: University of Montana Skaggs School of Pharmacy
Residency Training: PGY1: Seattle Children’s Hospital
Dan Pak, PharmD
Antimicrobial Stewardship and NICU
Pharmacy School: Philadelphia College of Pharmacy and Science
Residency Training: PGY1: Crozer Chester Medical Center
Ana Petrovic, RPh
Pediatric General Medicine/Surgery
Pharmacy School: University of Belgrade, Serbia
Residency Training: PGY1: Seattle Children’s Hospital
Jenni Rasiah, PharmD
Pediatric General Medicine/Surgery
Pharmacy School: Washington State University
Residency Training: PGY1: Seattle Children’s Hospital
Mary Reilly, PharmD
Hematology/Oncology
Pharmacy School: University of Colorado
Residency Training:
- PGY1: University of Kentucky
- PGY2 Pediatrics: University of Kentucky
Kyle Roberts, PharmD, BCPS, BCPPS, BCCCP
Neonatal and Cardiac Intensive Care
Pharmacy School: Idaho State University
Residency Training: PGY1: Saint Alphonsus Regional Medical Center
Beatrice Rosete, PharmD
Liver and Abdominal Transplant
Pharmacy School: Ernest Mario School of Pharmacy
Residency Training: PGY1: Children’s Hospital of Orange County
Inara Sipols, PharmD, BCOP
Hematology/Oncology
Pharmacy School: University of California, San Francisco (UCSF)
Residency Training:
- PGY1: University of Washington
- PGY2 Oncology: Seattle Children’s Hospital
Christy Smith, PharmD, BCPPS, BCCCP
Pediatric Intensive Care
Pharmacy School: Loma Linda University School of Pharmacy
Residency Training:
- PGY1: Maine Medical Center
- PGY2 Pediatrics: Children’s National
Nina Srour, PharmD, BCCCP
Cardiac Intensive Care
Pharmacy School: University of Colorado
Residency Training:
- PGY1: Houston Methodist Hospital
- PGY2 Critical Care: Houston Methodist Hospital
Connor Stuart, PharmD, BCPPS
Emergency Medicine
Pharmacy School: University of Tennessee College of Pharmacy
Residency Training:
- PGY1: Le Bonheur Children’s Hospital
- PGY2 Pediatrics: Le Bonheur Children’s Hospital
Hannah Sundquist, PharmD
Pediatric General Medicine/Surgery
Pharmacy School: University of Washington
Residency Training: PGY1: Valley Medical Center
Dave Villeneuve, PharmD
Pediatric General Medicine/Surgery
Pharmacy School: Washington State University
Residency Training: PGY1: Seattle Children’s Hospital
Rebecca Wilke, PharmD
Pediatric General Medicine/Surgery
Pharmacy School: University of Wisconsin
Residency Training: PGY1: Seattle Children’s Hospital
Megan Williams, PharmD
Hematology/Oncology
Pharmacy School: University of Colorado Anschutz Skaggs School of Pharmacy and Pharmaceutical Sciences
Residency Training:
- PGY1: Intermountain Health Primary Children’s Hospital
- PGY2: St. Jude Children’s Research Hospital
Past Residents for PGY1 Pharmacy Residency Program
|
Residency Year |
Name of Resident |
Residency Project |
Current Position |
|---|---|---|---|
|
2006-2007 |
Julie Ryu |
Established pilot ambulatory solid organ transplant.
|
Gilead Sciences, Senior Manager, Medical Affairs |
|
2007-2008 |
Tsingyi Koh
|
Effectiveness of a Pharmacist initiated antimicrobial management program in a pediatric teaching hospital. |
National University Hospital Singapore, Principal Clinical Pharmacist (Solid Organ Transplant/Pediatrics) |
|
2007-2008 |
Nicole Richardson |
Defining the Role of a Clinical Pediatric Emergency Department Pharmacist. |
Kootenai Health, Clinical Pharmacist |
|
2008-2009 |
Kristina M. Gonzalez |
Assess if a transitional program will have an impact on rejection episodes in the adolescent population. |
Christus Health: PGY1 Pharmacy Residency Coordinator |
|
2008-2009 |
Jennifer Nguyen |
Evaluation of Pharmacist Managed Enoxaparin in Pediatric Patients. |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2009-2010 |
David Villeneuve |
Valganciclovir Kinetics in Solid Organ Transplanted Infants and Young Children. Villeneuve D, Brothers A, Harvey E, et al. Valganciclovir dosing using area under the curve calculations in pediatric solid organ transplant recipients. Pediatr Transplant. 2013;17(1):80‐85. doi:10.1111/petr.12030 |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2009-2010 |
Sarah Tucker |
Effect of Pharmacist Provided Education on Family Confidence in Managing Common Chemotherapy Complications. |
Seattle Children’s Hospital, Oncology Beacon/Informatics Pharmacist (until 2024) |
|
2010-2011 |
Sarah Chumbley |
A pharmacist-run monitoring program for tobramycin in pediatric patients with cystic fibrosis. |
Seattle Children’s Hospital, Intensive Care, Clinical Pharmacist (until 2023) |
|
2010-2011 |
Katie Bridger |
An Analysis of Implementing a Status Epilepticus Algorithm in a Pediatric Emergency Department. |
Seattle Children’s Hospital, Pharmacy Operations and Distribution Pharmacist |
|
2011-2012 |
Jennifer Welsh |
The Physical and Chemical Stability of Iron Sucrose in Parenteral Nutrition for patients with Intestinal Failure.
|
Womack Army Medical Center, Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist. |
|
2011-2012 |
Bradley Mirashiro |
The impact of a clinical pharmacist presence in the pediatric inpatient psychiatry unit.
|
CVS Honolulu, Pharmacist |
|
2012-2013 |
Joanna Collins |
A Retrospective Analysis to Identify Factors Associated with Acute Kidney Injury in a Tertiary Pediatric Hospital. |
Seattle Children’s Hospital, Pharmacy Quality Safety Team, Pharmacist (until 2021) |
|
2012-2013 |
Melissa Sandley (Rees) |
Therapeutic Drug Monitoring in Pediatric Voriconazole Dosing |
Oregon Health and Science University (OHSU) Pediatric Hematology/Oncology and Bone Marrow Transplant Pharmacist |
|
2013-2014 |
Jennifer Rasiah (Higuchi) |
Use of gastric acid suppressants by pediatric inpatients transferred out of the intensive care unit |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2013-2014 |
Esther Park |
Vitamin D Supplementation in Adolescent Nonadherent CF Patients.
|
Seattle Children's Hospital, Manager, Pharmacy Quality Safety & Compliance |
|
2014-2015 |
Victoria Chadwick |
Standardizing clonidine use for dexmedetomidine withdrawal in pediatrics |
Swedish Medical Center, General Pediatrics and ICU, Clinical Pharmacist |
|
2014-2015 |
Rebecca Wilke |
Evaluation of vancomycin use in the pediatric intensive care unit of a large pediatric referral hospital |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2015-2016 |
Matt Stephens |
Impact on Acute Otitis Media Antibiotic Orders from Auralgan Market Removal |
Seattle Children’s Hospital, ICU Supervisor and Clinical Pharmacist |
|
2015-2016 |
Anna Zhen |
Impact of a Revised Approach to Documentation and Evaluation of Penicillin and Cephalosporin Allergies in Pediatric Patients |
Lucile Packard, General Medicine, Clinical Pharmacist |
|
2016-2017 |
Ana Petrovic |
Retrospective Review of High vs. Standard Infliximab Dose in the Treatment of Pediatric Acute Ulcerative Colitis |
Seattle Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2016-2017 |
Ronika Kalpage |
Vancomycin Area Under the Curve Monitoring in Pediatric Hematology, Oncology, and Bone Marrow Transplant Patients. |
Sutter Sacramento Women and Children’s Center, Clinical Pharmacist |
|
2017-2018 |
Jenna Nickless |
Evaluation of intravenous posaconazole dosing and pharmacokinetic target attainment in pediatric patients. Nickless JR, Bridger KE, Vora SB, Brothers AW. Evaluation of Intravenous Posaconazole Dosing and Pharmacokinetic Target Attainment in Pediatric Patients. J Pediatric Infect Dis Soc. 2019;8(4):365‐367. doi:10.1093/jpids/piy094 |
Seattle Children’s Hospital, Intensive Care, Per Diem, Clinical Pharmacist |
|
2017-2018 |
Macy Miller (Royston) |
Retrospective analysis of rabbit anti-thymocyte globulin versus basiliximab induction in pediatric liver transplant recipients. Newland DM, Royston MJ, McDonald DR, et al. Analysis of rabbit anti-thymocyte globulin vs basiliximab induction in pediatric liver transplant recipients. Pediatr Transplant. 2019;23(8):e13573. doi:10.1111/petr.13573 |
University of Minnesota Medical Center, Pediatric Clinical Pharmacist |
|
2018-2019 |
Paul Paratore |
Neutropenia in Pediatric Patients Receiving High-Dose Cephalexin: A Retrospective Analysis. |
Denver Health, Pediatric Clinical Pharmacist |
|
2018-2019 |
Emilie Lynch (Bergsma) |
Comparison of Argatroban and Heparin in Pediatric Patients: A Retrospective Case Controlled Review.
|
University of Florida (UF) Health Shand’s Children’s Hospital, Pediatric Hematology/Oncology/BMT Clinical Pharmacist Specialist |
|
2019-2020 |
Karyl Kanada |
Implementation of a Multidisciplinary Intravenous Immunoglobulin Guideline of Care for Chylothorax in Infants Following Cardiac Surgery: Infection Rates and Associated Costs. |
Seattle Children’s Hospital, Emergency Medicine Clinical Pharmacist |
|
2019-2020 |
Annie Park |
Enoxaparin Anti-Xa Monitoring Protocol in Hospitalized Pediatric Patients. |
Mary Bridge Children’s Hospital, Pediatric Hematology/Oncology Pharmacist |
|
2020-2021 |
Josh DeGrave |
Standardized Pharmacy-Driven Opioid Taper Guideline In Pediatric Acute Care. |
University of Wisconsin (UW) Health, Pediatric Clinical Pharmacist |
|
2020-2021 |
Grant Mason |
Implementation of a Therapeutic Drug Monitoring Protocol for Beta-Lactam Antibiotics in Pediatric Patients |
Children’s Hospital of LA (CHLA), Pediatric Clinical Pharmacist |
|
2021-2022 |
Filmon Emnetu |
Oral Amoxicillin Challenge for Penicillin Allergy De-Labeling in Pediatric Patients. |
Eli Lilly and Company, Clinical Trial Project Manager |
|
2021-2022 |
Sonya Barich |
Characterization of Triazole Antifungal Collaborative Practice Agreement Implementation in Pediatric Oncology Patients |
Seattle Children’s Hospital, Hematology Oncology Pharmacist |
|
2022-2023 |
Alexis Perry |
Differences in the Incidence of Clostridioides difficile associated diarrhea in pediatric hematology and oncology patients with ceftazidime or cefepime. |
Children’s Healthcare of Atlanta, Hematology Oncology and Bone Marrow Transplant Pharmacist |
|
2022-2023 |
Tracy Liu |
Evaluation of a Beta Lactam Therapeutic Drug Monitoring Protocol in Critically Ill Children on CRRT or ECMO |
Seattle Children’s Hospital, Heart Failure and Heart Transplant Pharmacist |
|
2022-2023 |
Leah Burns |
Interval Training: A Quality Improvement Initiative for Extended Interval Aminoglycoside Therapy in Pediatric Patients |
LeBonheur Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Kiara Light |
Bivalirudin Initial vs. First Therapeutic Infusion Rate |
Oregon Health and Science University (OHSU), General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Rachel Bonin |
Evaluation of Adverse Effects Associated with Undiluted Levetiracetam in Pediatric Status Epilepticus Patients in the Emergency Department |
Children’s Wisconsin, Hematology/Oncology Bone Marrow Transplant Pharmacist |
|
2023-2024 |
Michelle Palmer |
Optimization of Pharmacist Led IV to PO Therapeutic Interchange |
Seattle Children’s Hospital, Pharmacy Operations and Distribution Pharmacist |
|
2023-2024 |
Jasmine Gronek |
Optimization of Standardized Dosing of Pediatric Dosage Forms |
Phoenix Children’s Hospital, General Pediatrics, Clinical Pharmacist |
|
2023-2024 |
Katie McFarland |
Beta Lactam Therapeutic Drug Monitoring in Pediatric Patients on Extracorporeal Therapy |
Children’s Hospital of Colorado, General Pediatrics Float, Clinical Pharmacist |
|
2024-2025 |
Daisy Nash |
Iron and Erythropoiesis Stimulating Agent Use in National Level IV Neonatal Intensive Care Units |
Texas Children’s Hospital, NICU Clinical Pharmacy Specialist |
|
2024-2025 |
Emma Fleck |
Rates of Target Level Achievement with Crushed Posaconzole in Pediatric Patients |
Oregon Health and Science University (OHSU), Outpatient Pediatric Gastroenterology |
|
2024-2025 |
Kali Cira |
Incidence of Discordant aPTT and Bivalirudin Levels and Impact on Clinical Outcomes in Critically Ill Pediatric Patients Receiving VA-ECMO |
Phoenix Children’s Hospital, Cardiac ICU Clinical Pharmacy Specialist |
|
2025-2026 |
Reda Ali |
Rates of Delayed Gemtuzumab Infusion Reactions (IR) Pre- and Post- Implementation of Standardized Post-Infusion Prophylaxis |
Texas Children’s Hospital, PGY2 Pediatrics Resident (Hematology/Oncology focus) |
|
2025-2026 |
Sanika Mathew |
Assessment of Neonate and Infant Sirolimus Dosing Strategies Based on Therapeutic Drug Monitoring |
Children’s National, PGY2 Pediatrics Resident |
Past Residents for PGY2 Pediatrics Pharmacy Residency Program
|
Residency Year |
Name of Resident |
Residency Project |
Current Position |
|---|---|---|---|
|
2024–2025 |
Rachel Dittrich |
Evaluation of Sternal Wound Infections in Pediatric Cardiac Surgery Patients |
Primary Children’s Hospital, Pediatric Solid Organ Transplant Pharmacist |
|
2024–2025 |
Andy Tsai |
Diuretic Use in Mechanically Ventilated Pediatric Patients Receiving Maintenance Intravenous Fluids |
Phoenix Children's Hospital, General Pediatrics, Clinical Pharmacist |
|
2025–2026 |
Grace Tam |
Once Daily Immunosuppression of LCP Tacrolimus and Sirolimus in Pediatric Renal Transplant Patients |
Children’s National, Pediatric Solid Organ Transplant Clinical Pharmacy Specialist |
Past Residents for PGY2 Oncology Program
|
Residency Year |
Name of Resident |
Current Position |
|---|---|---|
|
2016–2017 |
Kristoffer Martinson, PharmD |
Hematology/Oncology and Bone Marrow Transplant Supervisor, Seattle Children's Hospital |
|
2017–2018 |
Inara Sipols, PharmD, BCOP |
Hematology/Oncology Clinical Pharmacist, Seattle Children's Hospital |
|
2018–2019 |
Evan Abrass, PharmD, BCOP |
Bone Marrow Transplant Pharmacist, Lurie Children’s Hospital |
|
2019–2020 |
Emilie Bergsma, PharmD |
Hematology/Oncology/Stem Cell Transplant Advanced Patient Care Pharmacist, University of Florida (UF) Health Shand’s Children’s Hospital |
|
2020–2021 |
Jerrica Eaton, PharmD |
Hematology Oncology Investigational Drug Pharmacist, Children’s Hospital of Alabama |
|
2021–2022 |
Jeremy Obordo, PharmD |
Hematology/Oncology and Bone Marrow Transplant Pharmacist, John’s Hopkins All Children’s Hospital |
|
2022–2023 |
Sonya Barich, PharmD |
Hematology/Oncology Clinical Pharmacist, Seattle Children's Hospital |
|
2023–2024 |
Alexis Perry, PharmD |
Hematology/Oncology and Bone Marrow Transplant Pharmacist, Children’s Healthcare of Atlanta |
|
2024–2025 |
Rachel Bonin, PharmD |
Hematology/Oncology and Bone Marrow Transplant Pharmacist, Children’s Wisconsin |
|
2025–2026 |
Leah Nelson, PharmD |
Hematology/Oncology and Bone Marrow Transplant Pharmacist, Children’s Healthcare of Atlanta |